Lingga, Mary Ann .

HRN: 26-32-38  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/03/2025
CEFUROXIME 1.5GM (VIAL)
02/03/2025
02/04/2025
IVT
1.5g
PTOR
Elective CS
Waiting Final Action 
02/04/2025
CEFAZOLIN 1GM (VIAL)
02/04/2025
02/04/2025
IVT
2GMS
ON CALL TO OR
LTCS
Waiting Final Action 
02/04/2025
CEFAZOLIN 1GM (VIAL)
02/04/2025
02/05/2025
IV
2 Grams
Every 8 Hours
S/P Repeat CS
Waiting Final Action 
02/04/2025
CEFUROXIME 500MG (TAB)
02/04/2025
02/10/2025
ORAL
500mg
2 Times A Day
S/P Repeat CS
Waiting Final Action 
02/05/2025
MUPIROCIN 2%, 15G (TUBE)
02/05/2025
02/11/2025
TOPICAL
Pea Size
Od
S/P CS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: